fda semaglutide warning november 2025 Beyond the Headlines: Letters to GLP-1 Compounders A network meta-analysis backed weight-loss

The story of GLP-1 therapy over the past decade has been one of the most rapid and consequential transformations in the history of metabolic medicine, moving from incretin-based diabetes management to a class of drugs that reduce cardiovascular events, appear to slow neurodegeneration, and now achieve weight loss magnitudes that rival bariatric surgery

But I think for my patients, the most equitable care would be to try medications first," Husain said

Weeks 5 through 12 involve dose escalation where side effects peak and weight starts dropping more noticeably

PlexusDx clinicians monitor your response at each check-in and can adjust your treatment plan if side effects outweigh benefits

Sleep got better

DOI: 10.1016/j.metcli.2025.01.010 Riera, C